Effectiveness and safety of ustekinumab for the treatment of psoriasis; six years of clinical experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness and safety of ustekinumab for the treatment of psoriasis; six years of clinical experience

Published:2023-08-02 Issue:1 Volume:34 Page:
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Gönülal Melis¹²^ORCID,Balcı Didem Didar¹^ORCID,Öztürk Aylin³^ORCID,Doğan Sinan⁴^ORCID

Affiliation:

1. Department of Dermatology, İzmir Tepecik Training and Research Hospital, University of Health Sciences, İzmir, Turkey

2. İzmir Faculty of Medicine, Department of Dermatology, University of Health Sciences, İzmir, Turkey

3. Department of Dermatology, Ankara City Hospital, Ankara, Turkey

4. Çiğli Regional Education Hospital, Department of Dermatology, Bakırçay University, İzmir, Turkey

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2023.2241941

Reference15 articles.

1. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis

2. A systematic review of worldwide epidemiology of psoriasis

3. Safety of biologics in psoriasis

4. Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

5. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities;Expert Review of Clinical Pharmacology;2024-04-02

2. Short-term effectiveness and potential factors of ustekinumab based on real-world data in Chinese psoriasis patients;Journal of Dermatological Treatment;2024-03-26

3. Ustekinumab for the treatment of plaque psoriasis: A 6 -year real -life tertiary institution experience;2024-01-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3